In breast carcinoma, CD40L is expressed on non-cancer cells from a tumor environment and protects CD40+ cancer cells through a caspase-independent pathway against apoptosis caused by cytotoxic agents (e.g., CDDP and PTX) and as a result, induces a multidrug resistance [81]. The gene discussed is CD40LG; the disease is cancer.